Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Inflammation-induced acute phase response in skeletal muscle and critical illness myopathy.

Langhans C, Weber-Carstens S, Schmidt F, Hamati J, Kny M, Zhu X, Wollersheim T, Koch S, Krebs M, Schulz H, Lodka D, Saar K, Labeit S, Spies C, Hubner N, Spranger J, Spuler S, Boschmann M, Dittmar G, Butler-Browne G, Mouly V, Fielitz J.

PLoS One. 2014 Mar 20;9(3):e92048. doi: 10.1371/journal.pone.0092048. eCollection 2014.

2.

Critical illness myopathy and GLUT4: significance of insulin and muscle contraction.

Weber-Carstens S, Schneider J, Wollersheim T, Assmann A, Bierbrauer J, Marg A, Al Hasani H, Chadt A, Wenzel K, Koch S, Fielitz J, Kleber C, Faust K, Mai K, Spies CD, Luft FC, Boschmann M, Spranger J, Spuler S.

Am J Respir Crit Care Med. 2013 Feb 15;187(4):387-96. doi: 10.1164/rccm.201209-1649OC. Epub 2012 Dec 13.

PMID:
23239154
3.

Impaired autophagy, chaperone expression, and protein synthesis in response to critical illness interventions in porcine skeletal muscle.

Banduseela VC, Chen YW, Kultima HG, Norman HS, Aare S, Radell P, Eriksson LI, Hoffman EP, Larsson L.

Physiol Genomics. 2013 Jun 17;45(12):477-86. doi: 10.1152/physiolgenomics.00141.2012. Epub 2013 Apr 9.

4.

The E3 ubiquitin ligase TRIM62 and inflammation-induced skeletal muscle atrophy.

Schmidt F, Kny M, Zhu X, Wollersheim T, Persicke K, Langhans C, Lodka D, Kleber C, Weber-Carstens S, Fielitz J.

Crit Care. 2014 Sep 29;18(5):545. doi: 10.1186/s13054-014-0545-6.

5.

Secreted Frizzled-Related Protein 2 and Inflammation-Induced Skeletal Muscle Atrophy.

Zhu X, Kny M, Schmidt F, Hahn A, Wollersheim T, Kleber C, Weber-Carstens S, Fielitz J.

Crit Care Med. 2017 Feb;45(2):e169-e183. doi: 10.1097/CCM.0000000000002056.

PMID:
27661566
6.

Understanding critical illness myopathy: approaching the pathomechanism.

Friedrich O, Fink RH, Hund E.

J Nutr. 2005 Jul;135(7):1813S-1817S.

7.

Long-term recovery In critical illness myopathy is complete, contrary to polyneuropathy.

Koch S, Wollersheim T, Bierbrauer J, Haas K, Mörgeli R, Deja M, Spies CD, Spuler S, Krebs M, Weber-Carstens S.

Muscle Nerve. 2014 Sep;50(3):431-6. doi: 10.1002/mus.24175. Epub 2014 Jul 14.

PMID:
24415656
8.
9.

Enhanced muscle shortening and impaired Ca2+ channel function in an acute septic myopathy model.

Friedrich O, Hund E, von Wegner F.

J Neurol. 2010 Apr;257(4):546-55. doi: 10.1007/s00415-009-5362-5. Epub 2009 Nov 4.

PMID:
19888622
10.

Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators.

Orfanos SE, Kotanidou A, Glynos C, Athanasiou C, Tsigkos S, Dimopoulou I, Sotiropoulou C, Zakynthinos S, Armaganidis A, Papapetropoulos A, Roussos C.

Crit Care Med. 2007 Jan;35(1):199-206. Erratum in: Crit Care Med. 2007 Apr;35(4):1224.

PMID:
17110873
12.

Critical illness polyneuropathy and myopathy in patients with acute respiratory distress syndrome.

Bercker S, Weber-Carstens S, Deja M, Grimm C, Wolf S, Behse F, Busch T, Falke KJ, Kaisers U.

Crit Care Med. 2005 Apr;33(4):711-5.

PMID:
15818093
13.

Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients.

Koch A, Gressner OA, Sanson E, Tacke F, Trautwein C.

Crit Care. 2009;13(3):R95. doi: 10.1186/cc7925. Epub 2009 Jun 19.

14.

Electrophoretic determination of the myosin/actin ratio in the diagnosis of critical illness myopathy.

Stibler H, Edström L, Ahlbeck K, Remahl S, Ansved T.

Intensive Care Med. 2003 Sep;29(9):1515-27. Epub 2003 Aug 12.

PMID:
12915938
15.

Interleukin-1 and tumor necrosis factor α blockade treatment of experimental polymyositis in mice.

Sugihara T, Okiyama N, Watanabe N, Miyasaka N, Kohsaka H.

Arthritis Rheum. 2012 Aug;64(8):2655-62. doi: 10.1002/art.34465.

16.

Dynamics of myosin degradation in intensive care unit-acquired weakness during severe critical illness.

Wollersheim T, Woehlecke J, Krebs M, Hamati J, Lodka D, Luther-Schroeder A, Langhans C, Haas K, Radtke T, Kleber C, Spies C, Labeit S, Schuelke M, Spuler S, Spranger J, Weber-Carstens S, Fielitz J.

Intensive Care Med. 2014 Apr;40(4):528-38. doi: 10.1007/s00134-014-3224-9. Epub 2014 Feb 15.

PMID:
24531339
17.

Endogenous glycosides in critically ill patients.

Berendes E, Cullen P, Van Aken H, Zidek W, Erren M, Hübschen M, Weber T, Wirtz S, Tepel M, Walter M.

Crit Care Med. 2003 May;31(5):1331-7.

PMID:
12771599
18.

Cell stress molecules in the skeletal muscle of GNE myopathy.

Fischer C, Kleinschnitz K, Wrede A, Muth I, Kruse N, Nishino I, Schmidt J.

BMC Neurol. 2013 Mar 12;13:24. doi: 10.1186/1471-2377-13-24.

19.

Critical illness myopathy and polyneuropathy.

Bird SJ, Rich MM.

Curr Neurol Neurosci Rep. 2002 Nov;2(6):527-33. Review.

PMID:
12359108
20.

Dysregulation of sodium channel gating in critical illness myopathy.

Teener JW, Rich MM.

J Muscle Res Cell Motil. 2006;27(5-7):291-6. Epub 2006 Jul 28. Review.

PMID:
16874452

Supplemental Content

Support Center